Trust Company of Vermont’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-135
| Closed | -$26.6K | – | 1063 |
|
|
2024
Q3 | $26.6K | Hold |
135
| – | – | ﹤0.01% | 611 |
|
|
2024
Q2 | $27.9K | Sell |
135
-13
| -9% | -$2.69K | ﹤0.01% | 563 |
|
|
2024
Q1 | $40.1K | Buy |
+148
| New | +$40.1K | ﹤0.01% | 517 |
|
|
2023
Q4 | – | Sell |
-135
| Closed | -$26.5K | – | 819 |
|
|
2023
Q3 | $26.5K | Hold |
135
| – | – | ﹤0.01% | 539 |
|
|
2023
Q2 | $28.4K | Hold |
135
| – | – | ﹤0.01% | 544 |
|
|
2023
Q1 | $27.2K | Hold |
135
| – | – | ﹤0.01% | 566 |
|
|
2022
Q4 | $29.4K | Sell |
135
-23
| -15% | -$5.01K | ﹤0.01% | 543 |
|
|
2022
Q3 | $31K | Buy |
158
+23
| +17% | +$4.51K | ﹤0.01% | 547 |
|
|
2022
Q2 | $29K | Buy |
+135
| New | +$29K | ﹤0.01% | 533 |
|
|
2022
Q1 | – | Sell |
-135
| Closed | -$51K | – | 400 |
|
|
2021
Q4 | $51K | Buy |
+135
| New | +$51K | ﹤0.01% | 482 |
|
|
2021
Q3 | – | Sell |
-135
| Closed | -$50K | – | 394 |
|
|
2021
Q2 | $50K | Hold |
135
| – | – | ﹤0.01% | 475 |
|
|
2021
Q1 | $39K | Sell |
135
-8
| -6% | -$2.31K | ﹤0.01% | 495 |
|
|
2020
Q4 | $36K | Buy |
143
+8
| +6% | +$2.01K | ﹤0.01% | 487 |
|
|
2020
Q3 | $31K | Buy |
+135
| New | +$31K | ﹤0.01% | 481 |
|